J. Goldman & CO LP Nuvasive Inc Transaction History

J. Goldman & CO LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$36.81 - $48.12 $3.77 Million - $4.93 Million	-102,550 Reduced 38.43%	164,329 $6.79 Million
Q4 2022 Feb 14, 2023	BUY	$35.68 - $44.71 $9.52 Million - $11.9 Million	266,879 New	266,879 $11 Million
Q3 2020 Nov 16, 2020	SELL	$47.43 - $60.75 $2.9 Million - $3.71 Million	-61,106 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.51 - $66.59 $1.3 Million - $1.99 Million	29,833 Added 95.4%	61,106 $3.4 Million
Q1 2020 May 15, 2020	SELL	$32.82 - $81.13 $3.68 Million - $9.11 Million	-112,248 Reduced 78.21%	31,273 $1.58 Million

Q4 2019 Feb 14, 2020	BUY	$60.96 - $77.7 $327,599 - $417,559	5,374 Added 3.89%	143,521 $11.1 Million
Q3 2019 Nov 14, 2019	BUY	$55.78 - $68.08 $7.71 Million - $9.41 Million	138,147 New	138,147 $8.76 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.